Neurocrine Biosciences (($NBIX)) has held its Q4 earnings call. Read on for the main highlights of the call. Neurocrine Biosciences’ earnings call ...

Canada’s Trans Mountain oil pipeline, which allows producers to sell crude to markets in Asia, could fill to capacity as ...

This is the conclusion of a recent analysis by commercial real estate investment firm Berkadia, which predicts Orlando will ...

American importers have been stockpiling the popular Italian bubbly Prosecco as a hedge against the possible impact of ...

A real estate firm predicts that Orlando's rents could spike by the end of the year due to high demand and limited supply.

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...

Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...

Q3 2025 Earnings Conference Call February 7, 2025 11:00 AM ETCompany ParticipantsTom Cook - Managing Director, ICRDan Thoren ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

The upgrade is based on Moody's expectation of robust earnings growth for Eli Lilly in the coming years. This growth is anticipated to be driven by the company's incretin portfolio, which includes ...

Q4 2024 Earnings Call Transcript February 6, 2025 MDU Resources Group, Inc. misses on earnings expectations. Reported EPS is $0.27 EPS, expectations were $0.31. Operator: Hello. My name is Constantine ...